{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:27:14Z","timestamp":1767144434935,"version":"build-2238731810"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bcmd.2024.102885","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T03:02:21Z","timestamp":1724122941000},"page":"102885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center"],"prefix":"10.1016","volume":"109","author":[{"given":"Jos\u00e9 Carlos","family":"Jaime-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Gonz\u00e1lez-Trevi\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"G\u00f3mez-De Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Campos-Bocardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata V.","family":"Barrag\u00e1n-Longoria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga Graciela","family":"Cant\u00fa-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar Homero","family":"Guti\u00e9rrez-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcmd.2024.102885_bb0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S1516-31802005000300002","article-title":"Incidence of aplastic anemia and agranulocytosis in Latin America--the LATIN study","volume":"123","author":"Hamerschlak","year":"2005","journal-title":"Sao Paulo Med. J."},{"issue":"11","key":"10.1016\/j.bcmd.2024.102885_bb0010","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2024.102885_bb0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.19236","article-title":"BSH Committee. Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.bcmd.2024.102885_bb0020","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41409-021-01332-8","volume":"56","author":"Iftikhar","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"10224","key":"10.1016\/j.bcmd.2024.102885_bb0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(20)30408-6","article-title":"Farewell Seguro popular","volume":"395","author":"Agren","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcmd.2024.102885_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.bcmd.2024.102885_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/bmt.2016.212","article-title":"The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants","volume":"52","author":"G\u00f3mez-Almaguer","year":"2017","journal-title":"Bone Marrow Transplant."},{"issue":"20","key":"10.1016\/j.bcmd.2024.102885_bb0040","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2019000722","article-title":"Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia","volume":"3","author":"Bejanyan","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.bcmd.2024.102885_bb0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1182\/blood.V48.1.63.63","article-title":"Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality","volume":"48","author":"Camitta","year":"1976","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2024.102885_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.bcmd.2024.102885_bb0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host diseasein human recipients of marrow from HLA-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.bcmd.2024.102885_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.V87.2.491.bloodjournal872491","article-title":"Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation","volume":"87","author":"Brodsky","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2024.102885_bb0065","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3324\/haematol.2014.109355","article-title":"First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy","volume":"99","author":"Yoshida","year":"2014","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bcmd.2024.102885_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00277-011-1163-x","article-title":"Danazol as first-line therapy for aplastic anemia","volume":"90","author":"Jaime-P\u00e9rez","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bcmd.2024.102885_bb0075","article-title":"Comparison of hematopoietic stem cell transplantation outcomes using matched sibling donors, haploidentical donors, and immunosuppressive therapy for patients with acquired aplastic anemia","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcmd.2024.102885_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0037-1963(00)90031-3","article-title":"Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--the European Group for Blood and Marrow Transplantation experience","volume":"37","author":"Bacigalupo","year":"2000","journal-title":"Semin. Hematol."},{"issue":"10","key":"10.1016\/j.bcmd.2024.102885_bb0085","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41409-021-01332-8","volume":"56","author":"Iftikhar","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.bcmd.2024.102885_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/theoncologist.2014-0218","article-title":"Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico","volume":"20","author":"Jaime-P\u00e9rez","year":"2015","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.bcmd.2024.102885_bb0095","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2352-3026(20)30410-5","article-title":"The state of haematopoietic cells transplantation in Latin America","volume":"8","author":"Jaimovich","year":"2021","journal-title":"Lancet Haematol."},{"issue":"10","key":"10.1016\/j.bcmd.2024.102885_bb0100","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1038\/s41409-021-01321-x","article-title":"The paradox of haematopoietic cell transplant in Latin America","volume":"56","author":"Jaimovich","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.bcmd.2024.102885_bb0105","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.bbmt.2020.09.007","article-title":"Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed\/refractory severe aplastic anemia","volume":"26","author":"Arcuri","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.bcmd.2024.102885_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12288-014-0397-x","article-title":"Improving outcome of aplastic Anaemia with HLA-matched sibling donor hematopoietic stem cell transplantation: an experience of Gujarat Cancer and Research Institute (GCRI)","volume":"31","author":"Raut","year":"2015","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"10","key":"10.1016\/j.bcmd.2024.102885_bb0115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2017.169862","article-title":"Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011","volume":"102","author":"Vaht","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bcmd.2024.102885_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/bmt.2013.115","article-title":"Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation","volume":"49","author":"Marsh","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.bcmd.2024.102885_bb0125","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ajh.26924","article-title":"Alemtuzumab in relapsed immune severe aplastic anemia: long-term results of a phase II study","volume":"98","author":"Aggarwal","year":"2023","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.bcmd.2024.102885_bb0130","doi-asserted-by":"crossref","first-page":"429.e1","DOI":"10.1016\/j.jtct.2021.02.014","article-title":"Haploidentical peripheral stem cell transplantation for young patients with severe aplastic anemia using post-transplantation cyclophosphamide and methotrexate","volume":"27","author":"Yang","year":"2021","journal-title":"Transplant Cell Ther."},{"issue":"7\u20138","key":"10.1016\/j.bcmd.2024.102885_bb0135","first-page":"16448","article-title":"Allogeneic hematopoietic stem cell transplantation for acquired severe aplastic anemia: a summary of a 20-year experience","volume":"133","author":"Zieli\u0144ska","year":"2023","journal-title":"Pol. Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.bcmd.2024.102885_bb0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbmt.2017.10.034","article-title":"Post-transplant cyclophosphamide as sole graft-versus-host disease prophylaxis is feasible in patients undergoing peripheral blood stem cell transplantation for severe aplastic anemia using matched sibling donors","volume":"24","author":"George","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.bcmd.2024.102885_bb0145","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12185-022-03506-6","article-title":"Allogeneic bone marrow transplantation for aplastic anemia","volume":"119","author":"Storb","year":"2024","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.bcmd.2024.102885_bb0150","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bcmd.2024.102885_bb0155","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3324\/haematol.2011.054841","article-title":"Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups","volume":"97","author":"Bacigalupo","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2024.102885_bb0160","article-title":"Comparison of hematopoietic stem cell transplantation outcomes using matched sibling donors, haploidentical donors, and immunosuppressive therapy for patients with acquired aplastic anemia","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bcmd.2024.102885_bb0165","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.bbmt.2016.01.012","article-title":"Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across different economic regions","volume":"22","author":"Kumar","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.bcmd.2024.102885_bb0170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1517\/14712598.5.5.617","article-title":"Haematopoietic stem cell transplantation to treat aplastic anaemia","volume":"5","author":"Jaime-Perez","year":"2005","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"4","key":"10.1016\/j.bcmd.2024.102885_bb0175","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1182\/blood-2007-03-081596","article-title":"Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia","volume":"110","author":"Schrezenmeier","year":"2007","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1016\/j.bcmd.2024.102886","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979624000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979624000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T20:14:44Z","timestamp":1725740084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979624000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S1079979624000639"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102885","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102885"}}